Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Filing Details

Accession Number:
0001209191-18-027403
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-05-02 16:58:08
Reporting Period:
2018-05-01
Accepted Time:
2018-05-02 16:58:08
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
19411 Magellan Health Inc MGLN Services-Hospitals (8060) 581076937
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1212067 M Barry Smith 55 Nod Road
Avon CT 06001
Chief Executive Officer Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Ordinary Common Stock, $0.01 Par Value Acquisiton 2018-05-01 13,375 $51.79 57,605 No 4 X Direct
Ordinary Common Stock, $0.01 Par Value Disposition 2018-05-01 13,375 $86.02 44,230 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 X Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Options (right to buy) Disposition 2018-05-01 13,375 $0.00 13,375 $51.79
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
254,125 2023-02-01 No 4 X Direct
Footnotes
  1. This transaction was effectuated pursuant to a Rule 10b-5-1 Plan.
  2. The number of securities reported represents an aggregate number of shares sold in multiple open market transactions at prices ranging from $84.70 to $86.8750, inclusive. The price reported represents the weighted average price. The Reporting Person undertakes to provide staff of the SEC, the issuer, or a stockholder of the issuer, upon request, the number of shares sold by the Reporting Person at each separate price within the range.
  3. All of the stock options in this tranche have vested in full.
  4. Not applicable.